Here are five things to know about the company’s stock.
1. AmSurg stock has posted positive gains of 2.64 percent over the past month, according to the report.
2. This week, AmSurg stock has a consensus rating of “buy.”
3. The company’s stock has a 52-week high of $72.85 and a 52-week low of $45.19.
4. AmSurg stock is up 10.48 percent during the last three months, according to the report.
5. AmSurg has a market cap of $3.4 billion.
More articles on transactions and valuation issues:
5 things to know about Orland Park’s new outpatient center
Buffalo Surgery Center groundbreaking delayed
Backus Center for Specialty Care could include ASC
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
